PMV Pharmaceuticals, Inc.
PMVP
$1.38
$0.042.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.27% | -0.01% | 14.35% | 0.71% | -21.64% |
| Total Depreciation and Amortization | -29.41% | 3.03% | 6.45% | -3.13% | -13.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.47% | 22.44% | 16.91% | -28.69% | 44.01% |
| Change in Net Operating Assets | 186.64% | -20,538.46% | -97.51% | -72.73% | 224.69% |
| Cash from Operations | 25.93% | -14.49% | 13.27% | -8.29% | -0.20% |
| Capital Expenditure | -- | -- | -1,600.00% | 109.09% | -175.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -96.67% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.72% | 12.81% | 53.49% | 9.66% | -61.81% |
| Cash from Investing | -158.72% | 12.90% | 53.34% | 9.48% | -61.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 930.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | 930.00% |
| Foreign Exchange rate Adjustments | -100.00% | 300.00% | -150.00% | 300.00% | -114.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,424.41% | -30.32% | 121.13% | -7.98% | -168.93% |